Published in J Exp Med on September 01, 1995
IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med (2003) 2.87
Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med (1997) 2.59
CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza. Immunol Rev (2006) 2.49
Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med (1999) 2.33
CD8 T cell memory in B cell-deficient mice. J Exp Med (1996) 1.97
Requirement for transforming growth factor beta1 in controlling T cell apoptosis. J Exp Med (2001) 1.82
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol (1997) 1.81
Rapid default transition of CD4 T cell effectors to functional memory cells. J Exp Med (2007) 1.69
Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling. Proc Am Thorac Soc (2006) 1.31
Transforming growth factor-beta suppresses the activation of CD8+ T-cells when naive but promotes their survival and function once antigen experienced: a two-faced impact on autoimmunity. Diabetes (2008) 1.25
Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc. J Exp Med (1999) 1.14
Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles. Clin Diagn Lab Immunol (2002) 1.04
Generation, persistence and plasticity of CD4 T-cell memories. Immunology (2010) 1.01
The TGF-beta-pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae. Respir Res (2010) 1.00
Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1. J Virol (2000) 0.98
Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis. Korean J Intern Med (2014) 0.97
CD4 T-cell memory can persist in the absence of class II. Philos Trans R Soc Lond B Biol Sci (2000) 0.94
Transforming growth factor-beta promotes 'death by neglect' in post-activated human T cells. Immunology (2001) 0.91
Regulatory T-cell-associated cytokines in systemic lupus erythematosus. J Biomed Biotechnol (2011) 0.90
Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2. Nat Commun (2014) 0.90
Review article: molecular signals and genetic reprogramming in peripheral T-cell differentiation. Immunology (2000) 0.84
Regulatory T cells in renal disease. Int J Clin Exp Med (2008) 0.79
Antiretroviral cytolytic T-lymphocyte nonresponsiveness: FasL/Fas-mediated inhibition of CD4(+) and CD8(+) antiviral T cells by viral antigen-positive veto cells. J Virol (1999) 0.79
The emergence of non-cytolytic NK1.1+ T cells in the long-term culture of murine tumour-infiltrating lymphocytes: a possible role of transforming growth factor-beta. Immunology (1996) 0.78
The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T cells. BMC Immunol (2013) 0.78
Short-Lived Antigen Recognition but Not Viral Infection at a Defined Checkpoint Programs Effector CD4 T Cells To Become Protective Memory. J Immunol (2016) 0.77
Proximal signaling control of human effector CD4 T cell function. Clin Immunol (2007) 0.77
Transforming growth factor beta1 attenuates ceramide-induced CPP32/Yama activation and apoptosis in human leukaemic HL-60 cells. Biochem J (1997) 0.77
Apoptosis: A Current Molecular Analysis. Pathol Oncol Res (1996) 0.77
T cell death and transforming growth factor beta1. J Exp Med (2001) 0.75
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell (1993) 20.72
A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods (1991) 16.64
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell (1993) 14.39
The transforming growth factor-beta family. Annu Rev Cell Biol (1990) 10.62
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med (1986) 9.86
Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature (1993) 9.81
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev (1994) 8.52
IL-4 directs the development of Th2-like helper effectors. J Immunol (1990) 7.20
Cytotoxic T-cell memory without antigen. Nature (1994) 6.55
Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol (1988) 6.51
Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature (1991) 5.80
TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell (1990) 4.28
Apoptosis. Immunol Today (1993) 4.23
Negative selection of lymphocytes. Cell (1994) 3.47
Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science (1993) 3.28
Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol Rev (1991) 3.21
Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med (1989) 3.06
T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science (1994) 3.00
Positive selection of lymphocytes. Cell (1994) 2.86
TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell (1993) 2.57
The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med (1993) 2.50
Response of naive antigen-specific CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements. J Exp Med (1992) 2.30
T and B memory cells. Cell (1994) 2.20
Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity (1994) 2.19
Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol (1991) 2.15
Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci U S A (1991) 2.13
Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today (1993) 2.09
Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst (1990) 2.06
Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol (1993) 1.81
The accessory function of murine intercellular adhesion molecule-1 in T lymphocyte activation. Contributions of adhesion and co-activation. J Immunol (1991) 1.81
Distinct regulation of lymphokine production is found in fresh versus in vitro primed murine helper T cells. J Immunol (1990) 1.73
Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur J Immunol (1993) 1.51
Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia (1993) 1.50
Interleukin-2 dependent culture of cytolytic T cell lines. Immunol Rev (1981) 1.46
Memory effectors: a potent, IL-4-secreting helper T cell population that develops in vivo after restimulation with antigen. J Immunol (1993) 1.45
Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J Immunol (1993) 1.27
Transforming growth factor beta induces myoblast differentiation in the presence of mitogens. Proc Natl Acad Sci U S A (1992) 1.16
Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. Br J Cancer (1993) 1.16
Promotion and inhibition of activation-induced apoptosis in T-cell hybridomas by oncogenes and related signals. Immunol Rev (1994) 1.12
Co-stimulation of T cell proliferation by transforming growth factor-beta 1. J Immunol (1991) 1.12
Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines. J Immunol (1993) 1.02
Analysis of CD4+ T cells that provide contact-dependent bystander help to B cells. J Immunol (1992) 0.96
Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med (1994) 0.95
Lymphokines and the immune response: the central role of interleukin-2. Curr Opin Immunol (1991) 0.90
T cell memory. Annu Rev Immunol (1998) 5.20
T cell subsets and the recognition of MHC class. Immunol Rev (1983) 5.00
Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol (2000) 4.73
Culture supernatants of a stimulated T-cell line have helper activity that acts synergistically with interleukin 2 in the response of B cells to antigen. Proc Natl Acad Sci U S A (1981) 3.28
Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med (1994) 3.02
Significance of Lyt phenotypes: Lyt2 antibodies block activities of T cells that recognize class 1 major histocompatibility complex antigens regardless of their function. Proc Natl Acad Sci U S A (1981) 2.95
Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med (2000) 2.91
The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol (2000) 2.90
Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol (1994) 2.86
Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J Immunol (1996) 2.76
Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med (1997) 2.59
Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays. J Exp Med (1983) 2.56
Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med (1999) 2.33
Response of naive antigen-specific CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements. J Exp Med (1992) 2.30
Qualitative changes accompany memory T cell generation: faster, more effective responses at lower doses of antigen. J Immunol (2000) 2.23
Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene (1990) 2.22
Production of a B cell growth-promoting activity, (DL)BCGF, from a cloned T cell line and its assay on the BCL1 B cell tumor. J Exp Med (1982) 2.22
Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J Immunol (1987) 2.19
Antigen-independent changes in naive CD4 T cells with aging. J Exp Med (1996) 2.14
Coclustering of CD4 (L3T4) molecule with the T-cell receptor is induced by specific direct interaction of helper T cells and antigen-presenting cells. Proc Natl Acad Sci U S A (1987) 2.04
Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci U S A (1996) 2.01
The specific direct interaction of helper T cells and antigen-presenting B cells. Proc Natl Acad Sci U S A (1986) 1.98
E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J (1999) 1.93
Two distinct stages in the transition from naive CD4 T cells to effectors, early antigen-dependent and late cytokine-driven expansion and differentiation. J Immunol (2000) 1.92
CD4(+) T cell effectors can become memory cells with high efficiency and without further division. Nat Immunol (2001) 1.88
Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J Immunol (1995) 1.74
Distinct regulation of lymphokine production is found in fresh versus in vitro primed murine helper T cells. J Immunol (1990) 1.73
Induction of B cell differentiation by T cell factors. I. Stimulation of IgM secretion by products of a T cell hybridoma and a T cell line. J Immunol (1981) 1.73
Long-term CD4+ memory T cells from the spleen lack MEL-14, the lymph node homing receptor. J Immunol (1992) 1.72
The Lyt phenotype of a long-term allospecific T cell line. Both helper and killer activities to IA are mediated by Ly-1 cells. Eur J Immunol (1981) 1.72
Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens. J Immunol (1984) 1.62
Helper cells activated by allogeneic H-2K or H-2D differences have a Ly phenotype distinct from those responsive to I differences. J Immunol (1979) 1.57
Xenogeneic human anti-mouse T cell responses are due to the activity of the same functional T cell subsets responsible for allospecific and major histocompatibility complex-restricted responses. J Exp Med (1983) 1.56
Continuously proliferating allospecific T cells. I. Specificity of cooperation with allogeneic B cells in the humoral antibody response to sheep erythrocytes. J Exp Med (1979) 1.54
Entry of naive CD4 T cells into peripheral lymph nodes requires L-selectin. J Exp Med (1994) 1.53
Memory effectors: a potent, IL-4-secreting helper T cell population that develops in vivo after restimulation with antigen. J Immunol (1993) 1.45
The significance of T-B collaboration across haplotype barriers. Cold Spring Harb Symp Quant Biol (1977) 1.44
T cell replacing factors in the B cell response to antigen. Immunol Rev (1982) 1.44
In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J Immunol (1998) 1.43
T-cell memory: new perspectives. Immunol Today (1993) 1.43
Small subunit of I-A subregion antigens determines the allospecificity recognized by a monoclonal antibody. Nature (1980) 1.38
Negative allogeneic effects in vitro. I. Allogeneic T cells markedly suppress the secondary antibody-forming cell response. J Immunol (1977) 1.30
Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. J Immunol (1995) 1.30
Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma. J Immunol (2000) 1.28
B cell response to T helper cell subsets. II. Both the stage of T cell differentiation and the cytokines secreted determine the extent and nature of helper activity. J Immunol (1991) 1.25
Production of Con A-induced helper T cell replacing factor requires a T cell and an Ia-positive non-T cells. J Immunol (1980) 1.23
Role of BCGFII in the differentiation to antibody secretion normal and tumor B cells. J Immunol (1985) 1.21
CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy. J Exp Med (1992) 1.20
Hallmarks of CD4 T cell immunity against influenza. J Intern Med (2011) 1.19
B cell stimulatory factor 1 (interleukin 4) is sufficient for the proliferation and differentiation of lectin-stimulated cytolytic T lymphocyte precursors. J Exp Med (1987) 1.17
Single cell analyses of cytokine production. Curr Opin Immunol (1997) 1.15
Transferable anergy: superantigen treatment induces CD4+ T cell tolerance that is reversible and requires CD4-CD8- cells and interferon gamma. J Exp Med (1997) 1.15
Analysis of histocompatibility requirements for proliferative and helper T cell activity. T cell populations depleted of alloreactive cells by negative selection. J Exp Med (1980) 1.14
Partial purification and characterization of a BCGFII from EL4 culture supernatants. J Immunol (1984) 1.13
Role of antigen-presenting cells in the polarized development of helper T cell subsets: evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages. Eur J Immunol (1994) 1.10
Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J Immunol (1995) 1.10
Regulation of isotype production by IL-4 and IL-5. Effects of lymphokines on Ig production depend on the state of activation of the responding B cells. J Immunol (1989) 1.06
Ly phenotypes and MHC recognition: the allohelper that recognizes K or D is a mature Ly123 cell. J Immunol (1979) 1.06
Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals. Int Immunol (1996) 1.06
B cell response to fresh and effector T helper cells. Role of cognate T-B interaction and the cytokines IL-2, IL-4, and IL-6. J Immunol (1991) 1.05
Fine specificity mapping of two allospecific T cell lines: recognition of private specificities in the H-2 IA subregion. Eur J Immunol (1981) 1.04
The defects in effector generation associated with aging can be reversed by addition of IL-2 but not other related gamma(c)-receptor binding cytokines. Vaccine (2000) 1.03
High antigen density and IL-2 are required for generation of CD4 effectors secreting Th1 rather than Th0 cytokines. J Immunol (1998) 1.03
Transcriptional repression of the IL-2 gene in Th cells by ZEB. J Immunol (1998) 1.01
The generation and maintenance of memory T and B cells. Immunol Today (1999) 1.00
TGF-beta1: immunosuppressant and viability factor for T lymphocytes. Microbes Infect (1999) 0.99
From naive to memory. Development and regulation of CD4+ T cell responses. Immunol Res (1998) 0.99
Regulation of T cell subsets from naive to memory. J Immunother (1998) 0.99
Evidence for two distinct activation states available to B lymphocytes. J Immunol (1984) 0.98
Association of Ly phenotypes, T cell function and MHC recognition. Fed Proc (1980) 0.97
Transforming growth factor-beta enhances the in vivo effector function and memory phenotype of antigen-specific T helper cells in experimental autoimmune encephalomyelitis. J Immunol (1992) 0.96
Regulation of the immune response T-cell interactions. CRC Crit Rev Immunol (1982) 0.96
Analysis of CD4+ T cells that provide contact-dependent bystander help to B cells. J Immunol (1992) 0.96
Alloreactivity, the development of the T cell repertoire and the understanding of T cell function. Immunol Rev (1978) 0.95
The cytokines IL-4, IFN-gamma, and IL-12 regulate the development of subsets of memory effector helper T cells in vitro. J Immunol (1995) 0.95
Distinct lymphokine production by CD4+ T cells isolated from mucosal and systemic lymphoid organs. Immunology (1993) 0.95
Age-related changes in CD4 T cells of T cell receptor transgenic mice. Mech Ageing Dev (1997) 0.94
Regulation of the IgM and IgA anti-dextran B1355S response: synergy between IFN-gamma, BCGF II, and IL 2. J Immunol (1985) 0.93
Significance of class 1 and class 2 major histocompatibility complex antigens: help to allogeneic K and D antigens does not involve I recognition. J Immunol (1981) 0.93
CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype. Clin Exp Immunol (2004) 0.93
Purification and partial sequence analysis of murine B cell growth factor II (interleukin 5). J Immunol (1987) 0.90
Negative allogeneic effects in vitro. II. Mapping of histocompatibility differences leading to allosuppression. J Immunol (1977) 0.89
A monoclonal T cell-replacing activity can act directly on B cells to enhance clonal expansion. J Exp Med (1982) 0.89
IL-2 receptor (Tac antigen) protein expression is down-regulated by the 5'-untranslated region of the mRNA. J Immunol (1990) 0.88
Interleukin 18: tipping the balance towards a T helper cell 1 response. J Exp Med (2001) 0.88
Frequency of allogeneic helper T cells responding to whole H-2 differences and to an H-2K difference alone. J Immunol (1979) 0.87
Apoptosis and Bcl-2 expression in cultured murine splenic T cells. Immunology (1995) 0.87
B cell immunodeficiency fails to develop in CD4-deficient mice infected with BM5: murine AIDS as a multistep disease. J Immunol (2001) 0.86
Induction of the H-2 D antigen during B cell activation. J Immunol (1989) 0.84
Role of Ia-positive cells in the production of T cell-replacing factors: blocking of factor production with anti-Ia serum. J Immunol (1980) 0.83
Both naive and memory CD4 T cell subsets become anergic during MAIDS and each subset can sustain disease. J Immunol (1994) 0.82
Recombinant follicle-stimulating hormone induces ovulation and tissue plasminogen activator expression in hypophysectomized rats. Endocrinology (1990) 0.82
'Break dancers' bursitis'. JAMA (1985) 0.81
CD4 T cell anergy in murine AIDS: costimulation via CD28 and the addition of IL-12 are not sufficient to rescue anergic CD4 T cells. J Immunol (1997) 0.81
Role of T cells in the B-cell response: glutaraldehyde-fixed T-helper hybridoma cells synergize with the lymphokine IL-4 to induce B-cell activation and proliferation. Immunology (1991) 0.81
Enhanced development of Th2-like primary CD4 effectors in response to sustained exposure to limited rIL-4 in vivo. J Immunol (1996) 0.79
TCR triggering of anergic CD4 T cells in murine AIDS induces apoptosis rather than cytokine synthesis and proliferation. J Immunol (1996) 0.79